Mainz Biomed N.V (MYNZ) Cash & Equivalents: 2020-2025
Historic Revenue - Interest and Investment Income for Mainz Biomed N.V (MYNZ) over the last 1 years, with Jun 2025 value amounting to $9.8 million.
- Mainz Biomed N.V's Cash & Equivalents fell 11.81% to $6.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $6.2 million, marking a year-over-year decrease of 11.81%. This contributed to the annual value of $6.2 million for FY2024, which is 11.81% down from last year.
- Per Mainz Biomed N.V's latest filing, its Cash & Equivalents stood at $6.2 million for Q2 2025, which was down 0.00% from $6.2 million recorded in Q4 2024.
- In the past 5 years, Mainz Biomed N.V's Cash & Equivalents ranged from a high of $30.0 million in Q1 2022 and a low of $6.2 million during Q4 2024.
- Moreover, its 3-year median value for Cash & Equivalents was $7.1 million (2024), whereas its average is $11.1 million.
- Its Revenue - Interest and Investment Income has fluctuated over the past 5 years, first spiked by 101.59% in 2022, then tumbled by 56.21% in 2024.
- Over the past 5 years, Mainz Biomed N.V's Revenue - Interest and Investment Income (Quarterly) stood at $10.0 million in 2021, then spiked by 101.59% to $20.2 million in 2022, then decreased by 23.87% to $15.4 million in 2023, then decreased by 14.09% to $13.2 million in 2024, then climbed by 15.96% to $9.8 million in 2025.
- Its last three reported values are $6.2 million in Q2 2025, $6.2 million for Q4 2024, and $7.1 million during Q2 2024.